Search
Search Results
##search.searchResults.foundPlural##
-
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3603PDF: 1595HTML: 11449Figures Haase: 172 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3656PDF: 3012HTML: 181 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1269HTML: 359PDF: 784 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
668PDF: 52HTML: 126 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2702PDF: 810HTML: 6491Untitled: 203Untitled: 167Untitled: 163Untitled: 186 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
1797PDF: 866HTML: 1738Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 140 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3485PDF: 830HTML: 6692 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3034PDF: 1064HTML: 1714 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3289PDF: 1237HTML: 2187Fi.1 Gritti.Rambaldi: 181 -
GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS
1694PDF: 1245HTML: 11427Figure1: 147Figure 2: 153 -
-
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6624PDF: 3527HTML: 716 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1712PDF: 775HTML: 10200Figures 1,2,3: 150 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
3992PDF: 1183HTML: 1941Table 1: 172 -
BETA-GLOBIN GENE MUTATIONS IN TURKISH CHILDREN WITH BETA-THALASSEMIA: RESULTS FROM A SINGLE CENTER STUDY
1566PDF: 657HTML: 1604Beta-globin Gene Mutations in Turkish Children with Beta-Thalassemia: Results from a Single Center Study: 165 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2384PDF: 753HTML: 1718 -
ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes
1217PDF: 1155HTML: 436 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
1911PDF: 570Suppl. Files: 263HTML: 148 -
PREVALENCE OF ß-THALASSEMIA MUTATIONS AMONG NORTHEASTERN IRANIAN POPULATION AND THEIR IMPACTS ON HEMATOLOGICAL INDICES AND APPLICATION OF PRENATAL DIAGNOSIS, A SEVEN-YEARS STUDY
2294PDF: 885HTML: 355Supplementary table 1: 187Some of the mutation detection samples: 184 -
RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA
1885PDF: 1584HTML: 14601Untitled: 183Untitled: 153 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2500PDF: 824HTML: 17436Fig1 Caligaris: 142Fig.2 Caliga: 175 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13163PDF: 922HTML: 7269 -
Clinical and laboratory features of Hemoglobin La Desirade variant in association with sickle cell and alpha thalassemia genes Clinical & laboratory features of Hb La Desirade trait and compound heterozygous for Hb La Desirade and HbS Hemoglobin.
1478PDF: 417HTML: 201 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2148PDF: 823HTML: 2057 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3007PDF: 1548HTML: 385 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2473PDF: 1076HTML: 120 -
A case of iron deficiency anemia with co-existing Hb Fontainebleau.
1255PDF: 727HTML: 2030Untitled: 276 -
-
-
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1307PDF: 728HTML: 930







